| Lung Large Cell Carcinoma studied in …STUDIED_INderived10 of 33show all (up to 200) |
|---|
| → studied in | NCT05198830Phase 2 · active not recruiting Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00334815Phase 2 · active not recruiting Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01386385Phase 1/Phase 2 · active not recruiting Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02186847Phase 2 · completed Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06996249recruiting Prospective Data Collection Initiative on Thoracic Malignancies · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01642251Phase 1/Phase 2 · completed Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03110978Phase 2 · active not recruiting Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01345851NA · active not recruiting Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05566223Phase 1/Phase 2 · withdrawn CISH Inactivated TILs in the Treatment of NSCLC · condition mapped ALIAS · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03845296Phase 2 · completed Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) · condition mapped CURATED_BROADER · 33 trials mapped (6 active) | — | — | Lung Large Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |